Pharmaceutical products

Tender description

This Framework Agreement is for the supply of generic medicines listed in Section Four (4) of the British National Formulary (BNF) to health boards across NHS Scotland. The Goods have been split into five (5) categories, each of which is identified as a ‘Lot’. Full details of each Lot are contained in section II.2 of this notice. Supply of Lamotrigine tablets and dispersible tablets to NHS Scotland. The Authority intended to award a multi-supplier unranked framework by product line to an envisaged maximum of six (6) Suppliers. Supply of Sodium Valproate in a range of presentations to NHS Scotland. The Authority intended to award a multi-supplier unranked framework by product line to an envisaged maximum of six (6) Suppliers. Supply of Levodopa/Carbidopa/Entacapone film coated tablets to NHS Scotland. The Authority intended to award a multi-supplier unranked framework by product line to an envisaged maximum of six (6) Suppliers. Supply of Carbamazepine in a range of presentations to NHS Scotland. The Authority intended to award a multi-supplier unranked framework by product line to an envisaged maximum of six (6) Suppliers. Supply of all other Generic Medicines to NHS Scotland. The Authority intended to award each line within this lot to a single supplier.